Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial
Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a page update or correction on ClinicalTrials.gov but does not modify the underlying study data or eligibility criteria.SummaryDifference0.0%

- Check18 days agoChange DetectedA newer revision label (v3.6.2) is now displayed, replacing the previous v3.6.0, indicating an update to the page's documentation/versioning metadata.SummaryDifference0.0%

- Check33 days agoChange DetectedThe study page now indicates that recruitment is closed ('No longer looking for participants') and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label was adjusted, and the page revision tag now shows v3.6.0.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, indicating an update to the site's revision metadata (an administrative UI/system change).SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new page version. This change is a metadata update and does not alter visible content or functionality.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page’s UI/version label was updated from Revision v3.5.2 to v3.5.3 on the bottom of the ClinicalTrials.gov record, without any changes to the underlying study details.SummaryDifference0.0%

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.